# Remifentanil Versus Morphine for Sedation of Premature Neonates With Respiratory Distress Syndrome

> **NCT00391105** · PHASE4 · COMPLETED · sponsor: **Federal University of Minas Gerais**

## Conditions studied

- Respiratory Distress Syndrome

## Interventions

- **DRUG:** Remifentanil

## Key facts

- **NCT ID:** NCT00391105
- **Lead sponsor:** Federal University of Minas Gerais
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04
- **Primary completion:** —
- **Final completion:** 2005-11
- **Target enrollment:** — (—)
- **Last updated:** 2006-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00391105

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00391105, "Remifentanil Versus Morphine for Sedation of Premature Neonates With Respiratory Distress Syndrome". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00391105. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*